Literature DB >> 28342982

Mastocarcinoma therapy synergistically promoted by lysosome dependent apoptosis specifically evoked by 5-Fu@nanogel system with passive targeting and pH activatable dual function.

Xiandi Zhu1, Yn Sun1, Di Chen1, Jingfeng Li1, Xia Dong1, Jie Wang2, Huaiwen Chen1, Ying Wang1, Fulei Zhang1, Jinaxin Dai1, Rogério P Pirraco3, Shangjing Guo4, Alexandra P Marques3, Rui L Reis3, Wei Li5.   

Abstract

This manuscript describes a synergistic therapy for mastocarcinoma by pH and temperature dual-sensitive nanogel, and effects of microstructure, composition and properties of nanogel on the cellular response mechanism. The extracellular internalization of nanogels was obviously enhanced, due to the passive targeting function at T>VPTT. Interestingly, the increased cytotoxicity was further synergistically enhanced by an unexpected apoptosis as evoked by the 5-fluorouracil loaded nanogel (FLNG). The systemically evaluation of the effectors generated from different sub-cellular organelles including endosome, lysosome, autophagosome confirmed that it was a lysomal dependent apoptosis. Such specific apoptosis was mainly attributed to its activatable protonated PEI at low pH, which caused lysosomal membrane destruction and lysosomal enzyme cathepsin B (Cat B) leakage. This Cat B was then translocated to the mitochondria resulting in mitochondrial membrane permeability increase and mitochondrial membrane potential (MMP) decrease, followed by cytochrome c (Cyt C) release. Cyt C was the main molecule that evoked apoptosis as reflected by overexpression of caspase 9. Additionally, such lysosome dependent, apoptosis was further enhanced by the passive cellular targeting at T>VPTT. Thus, the tumor growth inhibition was synergistically enhanced by the extracellular temperature dependent passive targeting and intracellular pH activatable lysosomal dependent apoptosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Drug delivery; Mastocarcinoma therapy; Nanogel; Passive targeting

Mesh:

Substances:

Year:  2017        PMID: 28342982     DOI: 10.1016/j.jconrel.2017.03.038

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Age-Related Lysosomal Dysfunctions.

Authors:  Lena Guerrero-Navarro; Pidder Jansen-Dürr; Maria Cavinato
Journal:  Cells       Date:  2022-06-20       Impact factor: 7.666

2.  Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.

Authors:  Yonghua Su; Nian Huang; Di Chen; Li Zhang; Xia Dong; Yun Sun; Xiandi Zhu; Fulei Zhang; Jie Gao; Ying Wang; Kexing Fan; Puichi Lo; Wei Li; Changquan Ling
Journal:  Int J Nanomedicine       Date:  2017-05-29

3.  Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis.

Authors:  Suoyuan Li; Tao Zhang; Weiguo Xu; Jianxun Ding; Fei Yin; Jing Xu; Wei Sun; Hongsheng Wang; Mengxiong Sun; Zhengdong Cai; Yingqi Hua
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

4.  Connecting lysosomes and mitochondria - a novel role for lipid metabolism in cancer cell death.

Authors:  Karin Bartel; Helmut Pein; Bastian Popper; Sabine Schmitt; Sudha Janaki-Raman; Almut Schulze; Florian Lengauer; Andreas Koeberle; Oliver Werz; Hans Zischka; Rolf Müller; Angelika M Vollmar; Karin von Schwarzenberg
Journal:  Cell Commun Signal       Date:  2019-07-29       Impact factor: 5.712

Review 5.  Lysosomal quality control of cell fate: a novel therapeutic target for human diseases.

Authors:  Sheng-Yu Zhu; Ren-Qi Yao; Yu-Xuan Li; Peng-Yue Zhao; Chao Ren; Xiao-Hui Du; Yong-Ming Yao
Journal:  Cell Death Dis       Date:  2020-09-30       Impact factor: 8.469

6.  Death Pathways of Cancer Cells Modulated by Surface Molecule Density on Gold Nanorods.

Authors:  Fulei Zhang; Yi Hou; Minhui Zhu; Bo Deng; Mengxin Zhao; Xiandi Zhu; Yun Sun; Di Chen; Cheng Jiang; Liming Wang; Chunying Chen; Huaiwen Chen; Han Chen; Hongliang Zheng; Wei Li
Journal:  Adv Sci (Weinh)       Date:  2021-09-15       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.